Clinical Trials Arena May 2, 2024
Justine Ra

Experts say that Project Optimus is a necessary reform in the oncology space, but one that should be applied with caution.

Alongside the multitude of guidance documents, recent years have seen the US Food and Drug Administration (FDA) ramp up workshops and project implementation efforts in a bid to drive innovation in drug development. Agency eyes have zeroed in on oncology, with the FDA Oncology Center of Excellence (OCE) introducing frameworks such as Project Optimus to reform the dose optimisation and dose selection paradigm in oncology drug development.

While the framework of Optimus is not new to drug development, it is relatively new to oncology. In non-deadly indications, researchers have been employing the framework for quite some time because the...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Clinical Trials, FDA, Govt Agencies, Pharma, Pharma / Biotech, Trends
Cell and Gene Therapies — Improving Access and Outcomes for Medicare and Medicaid Beneficiaries
Americans split on using weight loss drugs to treat obesity: Survey
ASHP to CMS: 'Change course' on drug pricing
New AI model predicts gene expression across human cell types
Most Ditch GLP-1 Drugs for Weight Loss Within a Year

Share This Article